Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
JOHNSON & JOHNSON | JNJ | Nyse +17 Other | 7,354,561 | 154.6 USD | Stock | |
JOHNSON & JOHNSON | 000943981 | Berne S.E. | - | 140 CHF | ||
JOHNSON & JOHNSON | JNJ | Deutsche Boerse AG | 929 | 141.9 EUR | ||
JOHNSON & JOHNSON | JNJ * | Mexican S.E. | 1,197 | 2,560 MXN | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 136 USD | ||
JOHNSON & JOHNSON | JNJ | Frankfurt | 3,193 | 141.5 EUR | ||
JOHNSON & JOHNSON | JNJ | Wiener Boerse | 32 | 141.6 EUR | ||
JOHNSON & JOHNSON | 0R34 | London S.E. | 1,193 | 149.3 USD | ||
JOHNSON & JOHNSON | JNJ | Börse Stuttgart | 506 | 142.2 EUR | ||
JOHNSON & JOHNSON | JNJ | Bolsa De Valores De Colombia | 23 | 5,89,000 COP | ||
JOHNSON & JOHNSON | JNJ | Lima | - | 144.5 USD | ||
JOHNSON & JOHNSON | JNJ | Santiago S.E. | - | 148.3 USD | ||
JOHNSON & JOHNSON | JNJ | BOERSE MUENCHEN | 2,565 | 142.2 EUR | ||
JOHNSON & JOHNSON | 4JNJ | Borsa Italiana | - | 139.6 EUR | ||
JOHNSON & JOHNSON | JNJ | Bulgaria S.E. | 6 | 138.7 EUR | ||
JOHNSON & JOHNSON | JNJCL | Santiago S.E. | - | 1,55,930 CLP | ||
JOHNSON & JOHNSON | JNJ_KZ | Kazakhstan S.E. | 12 | 153.6 USD | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 500 CHF | ||
JOHNSON & JOHNSON | JNJ | Buenos Aires S.E. +1 Other | 10,565 | 11,386 ARS | Stock | |
JOHNSON & JOHNSON | JNJD | Buenos Aires S.E. | 569 | 10.9 USD | ||
JOHNSON & JOHNSON | JNJB34 | Sao Paulo | 6,606 | 52.45 BRL | Stock | |
JOHNSON & JOHNSON | JNJ0 | Deutsche Boerse AG +1 Other | - | 13.5 EUR | Stock | |
JOHNSON & JOHNSON | JNJ | NEO Exchange | 9,822 | 20.71 CAD | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI | Nyse +7 Other | 6,209,235 | 69.02 USD | Stock | |
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Deutsche Boerse AG | 112 | 62.55 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI1 N | Mexican S.E. | 0 | 1,120 MXN | ||
JOHNSON CONTROLS INTERNATIONAL PLC | 0Y7S | London S.E. | 16 | 67.13 USD | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Börse Stuttgart | - | 63.43 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | BOERSE MUENCHEN | 110 | 63.32 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Frankfurt | 22 | 53.62 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Berne S.E. | - | - CHF | ||
JOHNSON OUTDOORS INC. | JOUT | Nasdaq | 73,401 | 36.94 USD | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | Bombay S.E. +1 Other | 33,134 | 146 INR | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | NSE India S.E. | 515,029 | 146.2 INR | ||
JOHNSON MATTHEY PLC | JMPLY | OTC Markets | 997 | 46.93 USD | Stock | |
JOHNSON PHARMACARE LIMITED | SUNSHINE6 | Bombay S.E. | 1,914,813 | 1.15 INR | Stock | |
JOHNSON MATTHEY PLC | JMAT | London S.E. +6 Other | 298,212 | 1,845 GBX | Stock | |
JOHNSON MATTHEY PLC | JMT2 | Deutsche Boerse AG | - | 21.1 EUR | ||
JOHNSON MATTHEY PLC | JMAT N | Mexican S.E. | - | 811 MXN | ||
JOHNSON MATTHEY PLC | JMT2 | Börse Stuttgart | - | 21.24 EUR | ||
JOHNSON MATTHEY PLC | JMT2 | BOERSE MUENCHEN | - | 21.72 EUR | ||
JOHNSON MATTHEY PLC | JMPLF | OTC Markets | 904 | 23.3 USD | ||
JOHNSON MATTHEY PLC | JMAT | Berne S.E. | - | - CHF |
News (681)
Companies (46)
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...
Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...
Johnson Controls International Plc specializes in the design, manufacturing and marketing of equipment for the regulation and safety of buildings. Net sales break down by family of products and services as follows: - building regulation, integrated manag ...
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...
Prism Johnson Limited is an India-based building materials company. The Company operates through four segments: Cement, Tile and Bath (HRJ), and Ready Mixed Concrete (RMC). The Cement segment has a cement production capacity of 5.6-meganewton tons at Satn ...
Johnson Service Group PLC provides textile rental and related services across the United Kingdom and the Republic of Ireland. The Company's Workwear business is a supplier of workwear and protective wear in the United Kingdom, offering these services thro ...
Insiders
Ms. Suzanne Johnson is Investment Services Manager at Seascape Capital Management LLC.
She joined the firm in 2011.
She ensures that our clients have a positive experience with both our firm and custodians.
From account opening to account service requests, she acts as a liaison to fulfill and exceed client expectations.
In addition to her client service role, Ms. Johnson acts as office manager, responsible for the bookkeeping and human resource functions for the firm.
She joins us from another local advisory firm, Weyland Capital Management, where she performed in a similar capacity as client account manager and office manager for almost six years.
Her diverse administrative experience was gained in executive support and project management roles in both start-up and established companies ranging from telecommunications, commercial loan underwriting, and defense industries.
Suzanne Johnson has a current job as a Director at Penticton Indian Band.
Suzanne Nora Johnson is currently the Chairman at Intuit, Inc., Co-Chairman-Trustees Board at The Brookings Institution, Chairman at The John & Mary R.
Markle Foundation, Inc., Independent Director at Pfizer Inc., Treasurer & Director at TechnoServe, Inc., Director at Pfizer, Inc., Director at Americas Frontier Fund, Trustee at the University of Southern California, Member of the American Academy of Arts & Sciences, Member of The World Economic Forum USA, Inc., Member of the American Red Cross, Inc., and Member of the Global Agenda Council.
Previously, she served as Vice Chairman at The Goldman Sachs Group, Inc., Chairman at Global Markets Institute, Independent Director at American International Group, Inc., Director-Governing Board at The American National Red Cross, and Independent Director at Visa, Inc. She also held positions as Director at The Goldman Sachs Foundation and Co-Chair-Trustees Board at Carnegie Institution of Washington.
Ms. Johnson completed her undergraduate studies at the University of Southern California and obtained a graduate degree from Harvard Law School.
No results for this search
- Stock Market
- Advanced search
- Suzanne Johnson